Notepad
The notepad is empty.
The basket is empty.
Free shipping possible
Please wait - the print view of the page is being prepared.
The print dialogue opens as soon as the page has been completely loaded.
If the print preview is incomplete, please close it and select "Print again".

Focal Controlled Drug Delivery

BookPaperback
Ranking79809in
CHF188.00

Description

The concept of focal controlled drug delivery has been applied for treating illnesses that are localized to a certain tissue or organ. Controlled drug delivery systems have been focused on oral extended release formulations and on systemic delivery of small drugs and peptides.
More descriptions

Details

ISBN/GTIN978-1-4899-7965-0
Product TypeBook
BindingPaperback
PublisherSpringer
Publishing date27/08/2016
EditionSoftcover reprint of the original 1st ed. 2014
Pages700 pages
LanguageEnglish
SizeWidth 155 mm, Height 235 mm, Thickness 36 mm
Weight1202 g
Article no.4462208
Publisher's article no.9781489979650
CatalogsBuchzentrum
Data source no.20575175
More details

Series

Author

ABRAHAM J. DOMB is Professor for Medicinal Chemistry and Biopolymers at the Faculty of Medicine of the Hebrew University in Jerusalem, Israel.  He earned bachelor´s degrees in chemistry, pharmacy and law studies and a Ph.D. in chemistry from Hebrew University. He did his postdoctoral training at MIT and Harvard University and was R&D manager at Nova Pharm in Baltimore between 1988 and 1992. His primary research interests are in biopolymers, controlled drug delivery, cancer therapy, nanoparticulate systems, and forensic sciences.  WAHID KHAN obtained his master´s degree and Ph.D. in pharmaceutics at the National Institute of Pharmaceutical & Educational Research (NIPER) in Mohali, India. He worked with Prof. Abraham J. Domb in The Hebrew University of Jerusalem, Israel, for his post-doctoral research. Currently, he is working as Assistant Professor in the Department of Pharmaceutics at NIPER in Hyderabad, India. His experience includes areas ranging from drug delivery and drug targeting to nanomedicine and biodesign of implantable medical devices.